Search filters

List of works by Julie Roda

A Phase I Trial of Interleukin-12 With Trastuzumab and Paclitaxel for HER2-Overexpressing Malignancies

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

scientific article

A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab

scientific article

Abstract 2686: Anti-tumor effects of a folate-immunoglobulin conjugate are enhanced by cytokine treatmentin vitroandin vivo

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody

scientific article

Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines

scientific article

Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma

scientific article published on 3 January 2008

CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells

scientific article

Fcγ receptor-induced soluble vascular endothelial growth factor receptor-1 (VEGFR-1) production inhibits angiogenesis and enhances efficacy of anti-tumor antibodies

scientific article published on 31 July 2013

Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model

scientific article published on 17 October 2012

Hypoxia-Inducible Factor α Subunits Regulate Tie2-Expressing Macrophages That Influence Tumor Oxygen and Perfusion in Murine Breast Cancer

scientific article published on 16 September 2020

Hypoxia-Inducible Factor-2α Regulates GM-CSF–Derived Soluble Vascular Endothelial Growth Factor Receptor 1 Production from Macrophages and Inhibits Tumor Growth and Angiogenesis ⬇️

scientific article published on July 15, 2011

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

scientific article published on 14 February 2011

IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro

scientific article published on 8 January 2008

Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects

scientific article published on August 2006

Interleukin-21 enhances NK cell activation in response to antibody-coated targets

scientific article published on July 2006

NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines

scientific article published on 10 February 2016

Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells

scientific article published on January 2006

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

scientific article

Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.

scientific article

Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model

scientific article

The Cellular Component of Chronic Inflammation

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

scientific article published on 25 October 2007

Paulina is supported by:

About Paulina

Help